山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (6): 38-44.doi: 10.6040/j.issn.1671-7554.0.2021.0380
郑凤杰,宋玉文,孙爱丽,潘喆,王殿辉,娄能俊,吕丽, 庄向华,陈诗鸿
ZHENG Fengjie, SONG Yuwen, SUN Aili, PAN Zhe, WANG Dianhui, LOU Nengjun, LYU Li, ZHUANG Xianghua, CHEN Shihong
摘要: 目的 探讨2型糖尿病患者糖尿病周围神经病变(DPN)与肌少症的关联性。 方法 选取2型糖尿病患者166例,根据骨骼肌质量指数、握力及步速分为肌少症组(n=62)与非肌少症组(n=104);有DPN的症状或体征、同时存在神经传导速度减慢的患者诊断为DPN。应用单因素分析及多因素Logistic回归分析进行统计学处理,比较两组患者的临床特征、生化指标及DPN患病率的差异。 结果 肌少症组患者的年龄大于非肌少症组,体质量指数、谷氨酸氨基转移酶水平、骨骼肌质量指数、握力、步速均低于非肌少症组(P<0.05)。肌少症组DPN的比例为83.87%,骨质疏松症比例为70.97%,均高于非肌少症组(P<0.05)。性别为男性(OR=0.025; 95%CI:0.004~0.143)及DPN(OR=32.927, 95%CI:6.169~175.742)为2型糖尿病患者发生肌少症的独立危险因素,而较高的体质指数是2型糖尿病患者发生肌少症的保护性因素(OR=0.546,95%CI:0.420~0.710)。 结论 DPN是2型糖尿病患者发生肌少症的独立危险因素,对于患有DPN的患者,应进行肌少症的临床筛查。
中图分类号:
[1] Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia [J]. J Am Med Dir Assoc, 2011, 12(4): 249-256. [2] 薛瑜, 王鸥, 邢小平. 肌少症筛查工具[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5):483-490. XUE Yu, WANG Ou, XING Xiaoping. Screening tools for sarcopenia [J]. Chinese Journal of Osteoporosis and Bone Mineral Research, 2017, 10(5):483-490. [3] Wu PY, Huang KS, Chen KM, et al. Exercise, nutrition, and combined exercise and nutrition in older adults with sarcopenia: a systematic review and network meta-analysis[J]. Maturitas, 2021, 145: 38-48. doi: 10.1016/j.maturitas.2020.12.009. [4] Beaudart C, Sanchez-Rodriguez D, Locquet M, et al. malnutrition as a strong predictor of the onset of sarcopenia [J]. Nutrients, 2019, 11(12):2883 [5] Dhillon RJ, Hasni S. Pathogenesis and management of sarcopenia [J]. Clin Geriatr Med, 2017, 33(1): 17-26. [6] Albers JW, Pop-Busui R. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes [J]. Curr Neurol Neurosci Rep, 2014, 14(8): 473. [7] Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [J]. Diabet Med, 1998, 15(7): 539-553. [8] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1):64-67. Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China(2017 Edition)[J]. Chinese Journal of Diabetes Mellitus, 2018, 10(1):64-67. [9] Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia [J]. J Am Med Dir Assoc, 2014, 15(2): 95-101. [10] 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5):413-444. Chinese Society of Osteoporosis and Bone Mineral Research. Guidelines for the diagnosis and management of primary osteoporosis(2017)[J]. Chinese Journal of Osteoporosis and Bone Mineral Research,2017, 10(5):413-444. [11] CruzJentoft AJ, Sayer AA. Sarcopenia[J]. Lancet, 2019, 393(10191): 2636-2646. [12] Wong R, Wong H, Zhang N, et al. The relationship between sarcopenia and fragility fracture-a systematic review [J]. Osteoporos Int, 2019, 30(3): 541-553. [13] Ryan AM, Prado CM, Sullivan ES, et al. Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival [J]. Nutrition, 2019, 67-68: 110539. doi: 10.1016/j.nut.2019.06.020. [14] 郭衍超,王霓雯,姚颖. 老年肌少症的研究进展[J]. 老年医学与保健, 2020, 26(1):4-8. [15] Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study(KSOS)[J]. Diabetes Care, 2010, 33(7): 1497-1499. [16] Yoon JW, Ha YC, Kim KM, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging [J]. Diabetes Metab J, 2016, 40(2): 140-146. [17] Tajiri Y, Kato T, Nakayama H, et al. Reduction of skeletal muscle, especially in lower limbs, in Japanese type 2 diabetic patients with insulin resistance and cardiovascular risk factors [J]. Metab Syndr Relat Disord, 2010, 8(2): 137-142. [18] Andreassen CS, Jakobsen J, Ringgaard S, et al. Accelerated atrophy of lower leg and foot muscles - a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging(MRI)[J]. Diabetologia, 2009, 52(6): 1182-1191. [19] Allen MD, Choi IH, Kimpinski K, et al. Motor unit loss and weakness in association with diabetic neuropathy in humans [J]. Muscle Nerve, 2013, 48(2): 298-300. [20] Resnick HE, Stansberry KB, Harris TB, et al. Diabetes, peripheral neuropathy, and old age disability [J]. Muscle Nerve, 2002, 25(1): 43-50. doi:10.1016/j.giatpost.2017.07.117. [21] Scarton A, Jonkers I, Guiotto A, et al. Comparison of lower limb muscle strength between diabetic neuropathic and healthy subjects using OpenSim [J]. Gait Posture, 2017, 58: 194-200. doi:10.1016/j.giatpost.2017.07.117. [22] Oh TJ, Song Y, Moon JH, et al. Diabetic peripheral neuropathy as a risk factor for sarcopenia [J]. Ann Geriatr Med Res, 2019, 23(4): 170-175. [23] Mege RM, Goudou D, Giaume C, et al. Is intercellular communication via gap junctions required for myoblast fusion? [J]. Cell Adhes Commun, 1994, 2(4): 329-343. [24] Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance [J]. Physiol Rev, 1996, 76(2): 371-423. [25] Allen MD, Kimpinski K, Doherty TJ, et al. Length dependent loss of motor axons and altered motor unit properties in human diabetic polyneuropathy [J]. Clin Neurophysiol, 2014, 125(4): 836-843. [26] Allen MD, Major B, Kimpinski K, et al. Skeletal muscle morphology and contractile function in relation to muscle denervation in diabetic neuropathy [J]. J Appl Physiol(1985), 2014, 116(5): 545-552. [27] Langer HT, Afzal S, Kempa S, et al. Nerve damage induced skeletal muscle atrophy is associated with increased accumulation of intramuscular glucose and polyol pathway intermediates [J]. Sci Rep, 2020, 10(1): 1908. [28] Bohnert KL, Hastings MK, Sinacore DR, et al. Skeletal muscle regeneration in advanced diabetic peripheral neuropathy [J]. Foot Ankle Int, 2020, 41(5): 536-548. [29] Toosizadeh N, Mohler J, Armstrong DG, et al. The influence of diabetic peripheral neuropathy on local postural muscle and central sensory feedback balance control [J]. PLoS One, 2015, 10(8): e135255. doi: 10.1371/journal.pone.0135255. [30] Bonewald LF, Kiel DP, Clemens TL, et al. Forum on bone and skeletal muscle interactions: summary of the proceedings of an ASBMR workshop [J]. J Bone Miner Res, 2013, 28(9): 1857-1865. [31] Chen Q, Zeng J, Chen Y, et al. Efficacy of Xianling Gubao capsule in treating sarco-osteopenia: Protocol for a systematic review and meta-analysis [J]. Medicine(Baltimore), 2019, 98(20): e15672. doi: 10.1097/MD.0000000000015672. [32] Verschueren S, Gielen E, ONeill TW, et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men [J]. Osteoporos Int, 2013, 24(1): 87-98. [33] 帅波, 沈霖, 杨艳萍, 等. 武汉地区中老年男性肌肉减少症与骨密度的相关性[J]. 中华骨质疏松和骨矿盐疾病杂志, 2016, 9(3):257-263. SHUAI Bo, SHEN Lin, YANG Yanping, et al. Relationship between sarcopenia and bone mineral density in middle-aged and elderly men in Wuhan area [J]. Chinese Journal of Osteoporosis and Bone Mineral Research, 2016, 9(3):257-263. [34] Tagliaferri C, Wittrant Y, Davicco MJ, et al. Muscle and bone, two interconnected tissues [J]. Ageing Res Rev, 2015, 21: 55-70. doi: 10.1016/j.arr.2015.03.002. [35] Cederholm T, Cruz-Jentoft AJ, Maggi S. Sarcopenia and fragility fractures [J]. Eur J Phys Rehabil Med, 2013, 49(1): 111-117. [36] 张栌尹,莫永珍,欧阳晓俊,等. 住院老年患者肌少症患病率及相关因素分析[J]. 老年医学与保健, 2021, 27(1): 64-67. ZHANG Luyin, MO Yongzhen, OUYANG Xiaojun, et al. Analysis of prevalence and related factors of sarcopenia in hospitalized elderly patients[J]. Geriatrics & Health Care, 2021, 27(1): 64-67. [37] Rong Y, Bian A, Hu H, et al. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10 [J]. BMC Geriatrics, 2018, 18(1):308.. [38] Moon JS, Yoon JS, Won KC, et al. The role of skeletal muscle in development of nonalcoholic Fatty liver disease [J]. Diabetes Metab J, 2013, 37(4): 278-285. [39] Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People [J]. Age Ageing, 2010, 39(4): 412-423. [40] Papadopoulou SK. Sarcopenia: a contemporary health problem among older adult populations [J]. Nutrients, 2020, 12(5):1293. [41] Verschueren S, Gielen E, ONeill TW, et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men [J]. Osteoporos Int, 2013, 24(1): 87-98. [42] Vespasiani-Gentilucci U, De Vincentis A, Ferrucci L, et al. Low Alanine aminotransferase levels in the elderly population: frailty, disability, sarcopenia, and teduced survival [J]. J Gerontol A Biol Sci Med Sci, 2018, 73(7): 925-930. [43] Chung SM, Moon JS, Yoon JS, et al. Low alanine aminotransferase levels predict low muscle strength in older patients with diabetes: a nationwide cross-sectional study in Kore a[J]. Geriatr Gerontol Int, 2020, 20(4): 271-276. |
[1] | 于书卷,王美娟,陈丽,曹英娟,吕晓燕,刘雪燕,林鹏,颜景政. 老年2型糖尿病患者轻度认知功能障碍的影响因素[J]. 山东大学学报 (医学版), 2022, 60(11): 108-112. |
[2] | 吕丽,姜璐,陈诗鸿,庄向华,宋玉文,王殿辉,安文娟,李倩,潘喆. 210例绝经后2型糖尿病发生骨质疏松的相关因素[J]. 山东大学学报 (医学版), 2021, 59(7): 19-25. |
[3] | 刘萍,宋玉文,王萍,田光伟,郑凤杰,吕丽,杜娇娇,张静,庄向华,陈诗鸿. 维生素D缺乏与2型糖尿病合并抑郁状态的相关性[J]. 山东大学学报 (医学版), 2021, 59(6): 51-56,102. |
[4] | 刘晓菲,梁瀛,张丛溪,王娟,潘云,徐嘉蔚,常春,董亮. 92例哮喘患者血清瘦素与诱导痰嗜酸性粒细胞的关系[J]. 山东大学学报 (医学版), 2020, 1(9): 27-33. |
[5] | 张宝文,雷香丽,李瑾娜,罗湘俊,邹容. miR-21-5p靶向调控TIMP3抑制2型糖尿病肾病小鼠肾脏系膜细胞增殖及细胞外基质堆积[J]. 山东大学学报 (医学版), 2020, 1(7): 7-14. |
[6] | 王余余,高丽,陈少华. 94例2型糖尿病患者急性脑梗死后认知障碍与甲状腺功能的关联性[J]. 山东大学学报 (医学版), 2020, 58(5): 56-61. |
[7] | 唐博,邵静,崔静,孙健平. 2型糖尿病发病与高密度脂蛋白关系的机制研究[J]. 山东大学学报 (医学版), 2020, 58(3): 99-106. |
[8] | 金海燕,张炎,马小莉,韩羽,赵蕙琛,刘元涛,张玉超. MiR-122与miR-33a在2型糖尿病合并冠心病患者中的表达[J]. 山东大学学报 (医学版), 2020, 58(3): 94-98. |
[9] | 宋海霞,袁彩霞,范玲玲. 体质量指数对夫精人工授精妊娠结局的影响[J]. 山东大学学报 (医学版), 2020, 58(1): 49-53. |
[10] | 曾雁冰,王秋鹏,方亚. 厦门市糖尿病“三师共管”模式的卫生经济学评价[J]. 山东大学学报 (医学版), 2019, 57(8): 89-94. |
[11] | 姜立娟,刘福强,蒋子允,李文娟,林鹏,王川,侯新国,陈丽. 达格列净改善超重及肥胖2型糖尿病患者脂代谢及内脏脂肪含量[J]. 山东大学学报 (医学版), 2019, 57(6): 87-93. |
[12] | 杜昊,程玉刚,黄鑫,刘少壮,张光永,胡三元. 袖状胃切除术对2型糖尿病大鼠肺组织损伤的影响[J]. 山东大学学报 (医学版), 2019, 57(4): 20-26. |
[13] | 徐琼琼,郭晓雷,楚洁,景正月,张新益,周成超. 山东省2型糖尿病患者健康相关生命质量及其影响因素[J]. 山东大学学报 (医学版), 2019, 57(3): 96-103. |
[14] | 刘萍,庄向华,徐敏,张亮,王雪萌,尚攀,郑凤杰,陈诗鸿. 西格列汀在糖尿病周围神经病变中的效果[J]. 山东大学学报 (医学版), 2019, 57(3): 58-62. |
[15] | 田忠艳,李玉倩,刘晓田,史园园,张海庆,张霞,千新玲,尹磊,赵景志,王重建. PSMD6基因rs831571位点多态性与2型糖尿病易感性的病例对照研究[J]. 山东大学学报 (医学版), 2018, 56(7): 51-56. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 455
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 1451
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Cited |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Shared | ||||||||||||||||||||||||||||||||||||||||||||||||||
Discussed |
|